Advances in Pharmaceutical Biotechnology: Volume 2: Current Developments in Biopharmaceuticals
暫譯: 藥物生物技術進展：第二卷：生物製藥的最新發展
Chavda, Vivek P., Chen, Zhe-Sheng (Jason)
- 出版商: Apple Academic Press
- 出版日期: 2026-03-19
- 售價: $9,850
- 貴賓價: 9.8 折 $9,653
- 語言: 英文
- 頁數: 490
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 177491980X
- ISBN-13: 9781774919804
-
相關分類:
物聯網 IoT
海外代購書籍(需單獨結帳)
相關主題
商品描述
This comprehensive new two-volume work provides detailed explanations of the procedures involved in the development and manufacture of biopharmaceuticals as well as the uses and applications in healthcare and medicine.
Volume 1 offers an introduction and overview of pharmaceutical technology, covering the principals and science of biotechnology. It explains genetic engineering that involves laboratory-based technologies to alter the DNA makeup of an organism; protein engineering to develop valuable proteins through the design and production of unnatural polypeptides; recombinant DNA technology to manipulate and isolate DNA segments of interest; and microbial biotransformation, which transforms absorbed nutrients (food, oxygen, etc.) into substances required for normal body functions.
商品描述(中文翻譯)
這部全面的新雙卷本作品詳細解釋了生物製藥的開發和製造過程，以及在醫療和醫學中的用途和應用。
第一卷提供了製藥技術的介紹和概述，涵蓋了生物技術的原則和科學。它解釋了基因工程，這涉及基於實驗室的技術來改變生物體的DNA組成；蛋白質工程，通過設計和生產不自然的多肽來開發有價值的蛋白質；重組DNA技術，用於操控和分離感興趣的DNA片段；以及微生物生物轉化，將吸收的營養物質（食物、氧氣等）轉化為正常身體功能所需的物質。
作者簡介
Vivek P. Chavda, MPharm, is an Assistant Professor of Pharmaceutics and Pharmaceutical Technology at the L. M. College of Pharmacy, India. Before joining academia, he served in the biologics industry for almost eight years in research and development and has two successful regulatory filings at Lupin Biotech and Dr. Reddy's Laboratory. He has published over 250 papers in national and international publications, nearly 20 book chapters, and several books, and has seven patents in progress. His research interests include development of biologics processes and formulations, medical device development, nano-diagnostics, long-acting parenteral formulations, and nano-vaccines. He is listed among the world's top 2% of scientists in 2023 and 2024 by Stanford University and Elsevier.
Zhe-Sheng (Jason) Chen, MD, PhD, a Professor at the College of Pharmacy and Health Sciences at St. John's University, New York, USA. Dr. Chen is editor-in-chief of Drug Resistance Updates, Recent Patents on Anticancer Drugs Discovery, Journal of Cancer Research Updates, and New Developments on Chemistry, as well as a guest editor for Current Pharmaceutical Biotechnology and an editorial board member and reviewer for many journals. He is also an ad hoc grants reviewer for the National Institutes of Health (USA) and NCI Special Emphasis Review Panel, OmniBus SEP-10, as well as a state grant reviewer for Louisiana and a reviewer for grants for New Zealand, Poland, China, Hungary, Netherlands, etc. The author of many papers, he was included on Stanford/Elsevier's world's top 2% scientists list in 2024. He is also a consultant to pharmaceutical, biotechnology, and health industry organizations.
作者簡介(中文翻譯)
Vivek P. Chavda, MPharm 是印度 L. M. 藥學院的藥劑學與藥物技術助理教授。在進入學術界之前，他在生物製劑產業工作了近八年，專注於研究與開發，並在 Lupin Biotech 和 Dr. Reddy's Laboratory 有兩項成功的法規申請。他在國內外出版了超過 250 篇論文，近 20 篇書章，以及幾本書籍，並有七項專利正在進行中。他的研究興趣包括生物製劑的工藝與配方開發、醫療器械開發、奈米診斷、長效注射劑配方以及奈米疫苗。他在 2023 年和 2024 年被史丹佛大學和 Elsevier 列為全球前 2% 科學家之一。
Zhe-Sheng (Jason) Chen, MD, PhD 是美國紐約聖約翰大學藥學與健康科學學院的教授。陳博士是 Drug Resistance Updates、Recent Patents on Anticancer Drugs Discovery、Journal of Cancer Research Updates 和 New Developments on Chemistry 的主編，同時也是 Current Pharmaceutical Biotechnology 的客座編輯，以及多本期刊的編輯委員會成員和審稿人。他還是美國國立衛生研究院 (NIH) 和 NCI 特別重點審查小組 OmniBus SEP-10 的臨時補助審查員，並擔任路易斯安那州的州補助審查員，以及新西蘭、波蘭、中國、匈牙利、荷蘭等國的補助審查員。他是多篇論文的作者，於 2024 年被列入史丹佛/Elsevier 全球前 2% 科學家名單。他同時也是製藥、生物技術和健康產業組織的顧問。
